Apr 29, 2026
BPI Europe: Intensification is dropping the cost of up- and downstream mAb-making
At the BioProcess International Europe event, industry expert Jean-Marc Cappia emphasized the transformative impact of process intensification on monoclonal antibody (mAb) manufacturing, highlighting significant cost reductions and efficiency improvements.Cappia outlined how the integration of advanced technologies like single-use systems, perfusion bioreactors, and continuous capture platforms has driven down production costs from approximately $500 per gram to under $100 per gram in the last d